|
|
|
|
||
Re: Tracking Cancer Gene Editing Partnerships: Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of CancerImmunology remains unpartnerted, but SGMO wants to commercialize some portions of the business themselves. Maybe celgene can get lucky there? The patent estate that SGMO appears to have will require more lawyers to defend everything too. Sick of that! |
return to message board, top of board |